接受血栓切除术患者的多血管闭塞:患病率、相关因素及临床意义
从前瞻性登记中提取720例连续血管内治疗候选者的影像数据,多模态MRI/CT评估并由动脉造影确认多血管闭塞(MVO)。MVO患病率10.7%(95%CI 6.4%-13.0%),初始影像报告检出率54.5%;MVO与较低的成功再灌注率(aOR 0.549)和较低的良好功能结局率(aOR 0.437)相关。
要点
- MVO患病率10.7%(95%CI 6.4%-13.0%),初始影像报告检出率仅54.5%。
- MVO独立相关因素:他汀治疗aOR 0.477、收缩压每升高1 mmHg aOR 1.014、原发闭塞部位M2 aOR 1.870。
- MVO与较低成功再灌注率(aOR 0.549)和较低良好功能结局率(aOR 0.437)相关。
核心结论
- 本系列中每十例因血管内卒中治疗接受造影的患者即有一例存在MVO,仅半数在介入前诊断影像中被前瞻性识别。
- MVO影响治疗决策,对血管内治疗成功产生负面影响,并预测更差的临床结局。
- MVO患者基线收缩压更高且较少接受他汀治疗,该观察需外部验证并评估因果关系。
研究设计与样本
- 从前瞻性登记中提取720例连续血管内治疗候选者且可直接进入造影的影像数据。
- 采用多模态磁共振成像/计算机断层扫描评估MVO患病率,并由动脉内造影确认。
- 采用多变量逻辑回归分析相关因素与临床相关性,纳入单变量比较中P<0.15的变量。
- 良好功能结局定义为第90天改良Rankin量表评分≤2分。
主要发现
- MVO存在于10.7%的患者中(95%CI 6.4%-13.0%)。
- MVO病例中2处、3处和4处伴随闭塞分别占80.5%、16.9%和2.6%。
- 初始放射学报告检出率为54.5%。
- 下游MVO约占MVO的三分之一(n=27/77,35.1%),其余MVO(n=50/77,64.9%)发生于不同血管区域。
- 与MVO独立相关的因素:他汀治疗(aOR 0.477;95%CI 0.276-0.827)、较高收缩压(每升高1 mmHg的aOR 1.014;95%CI 1.005-1.023)、原发闭塞部位M2(aOR 1.870;95%CI 1.103-3.170)。
局限性
- 原文指出MVO患者基线收缩压更高且较少接受他汀治疗的观察需外部验证并评估因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Patients with embolic large-vessel occlusion may present with additional coincidental acute occlusions within or distant from the involved territory, referred to as multivessel occlusion (MVO). Purpose of this study was to assess prevalence of MVO, associated factors, and clinical relevance in patients undergoing endovascular stroke treatment. METHODS: Image data of consecutive endovascular candidates (n=720) with direct access to angiography were extracted from a prospective registry. Prevalence of MVO was assessed with multimodal magnetic resonance imaging/computed tomography and confirmed by intra-arterial angiography. Explorative analysis of associated factors and clinical relevance was evaluated using multivariable logistic regression including variables with P<0.15 in univariate comparison. Good functional outcome was defined as modified Rankin Scale score ≤2 at day 90. RESULTS: MVO was present in 10.7% of patients (95% confidence interval [CI], 6.4%-13.0%). Two, 3, and 4 concomitant occlusions were found in 80.5%, 16.9%, and 2.6% of MVO cases, respectively. Detection rate on initial radiological report was 54.5%. Downstream MVO was present in around one third of MVO (n=27/77, 35.1%), whereas all other MVO (n=50/77, 64.9%) occurred in different territories. Independent factors related to MVO were statin treatment (adjusted odds ratio [aOR], 0.477; 95% CI, 0.276-0.827), higher systolic blood pressure (aOR per mm Hg increase, 1.014; 95% CI, 1.005-1.023), and primary occlusion site M2 (aOR, 1.870; 95% CI, 1.103-3.170). MVO was related to lower rates of successful reperfusion (aOR, 0.549; 95% CI, 0.316-0.953) and lower rates of good functional outcome (aOR, 0.437; 95% CI, 0.207-0.923). CONCLUSIONS: Every tenth patient subjected to angiography for endovascular stroke treatment experienced MVO in our series, and only half were prospectively identified on preinterventional diagnostic imaging. Patients with MVO had higher baseline systolic blood pressure and were less often medicated with statins, an observation that warrants external validation and evaluation regarding causality. Occurrence of MVO has implication for treatment decisions, negatively affects endovascular treatment success, and is predictive of worse clinical outcome.
引用
- Kaesmacher J, Mosimann PJ, Giarrusso M, et al. Multivessel Occlusion in Patients Subjected to Thrombectomy: Prevalence, Associated Factors, and Clinical Implications. Stroke. 2018. PMID: 29769241. doi:10.1161/STROKEAHA.118.021276
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。